Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 11
2004 10
2005 7
2006 17
2007 6
2008 9
2009 5
2010 7
2011 12
2012 14
2013 5
2014 9
2015 16
2016 10
2017 12
2018 25
2019 21
2020 11
2021 18
2022 15
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group. Marso SP, et al. N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605603 Free PMC article. Clinical Trial.
A hyperaldosteronism subtypes predictive model using ensemble learning.
Karashima S, Kawakami M, Nambo H, Kometani M, Kurihara I, Ichijo T, Katabami T, Tsuiki M, Wada N, Oki K, Ogawa Y, Okamoto R, Tamura K, Inagaki N, Yoshimoto T, Kobayashi H, Kakutani M, Fujita M, Izawa S, Suwa T, Kamemura K, Yamada M, Tanabe A, Naruse M, Yoneda T; JPAS/JRAS Study Group. Karashima S, et al. Sci Rep. 2023 Feb 21;13(1):3043. doi: 10.1038/s41598-023-29653-2. Sci Rep. 2023. PMID: 36810868 Free PMC article.
International multicenter survey on screening and confirmatory testing in primary aldosteronism.
Naruse M, Murakami M, Katabami T, Kocjan T, Parasiliti-Caprino M, Quinkler M, St-Jean M, O'Toole S, Ceccato F, Kraljevic I, Kastelan D, Tsuiki M, Deinum J, Torre EM, Puar T, Markou A, Piaditis G, Laycock K, Wada N, Grytaas MA, Kobayashi H, Tanabe A, Tong CV, Gallego NV, Gruber S, Beuschlein F, Kürzinger L, Sukor N, Azizan EABA, Ragnarsson O, Nijhoff MF, Maiolino G, Dalmazi GD, Kalugina V, Lacroix A, Furnica RM, Suzuki T. Naruse M, et al. Among authors: suzuki t. Eur J Endocrinol. 2023 Jan 10;188(1):lvac002. doi: 10.1093/ejendo/lvac002. Eur J Endocrinol. 2023. PMID: 36726325
Oxidative stress and acute lung injury.
Chow CW, Herrera Abreu MT, Suzuki T, Downey GP. Chow CW, et al. Among authors: suzuki t. Am J Respir Cell Mol Biol. 2003 Oct;29(4):427-31. doi: 10.1165/rcmb.F278. Am J Respir Cell Mol Biol. 2003. PMID: 14500253 Review. No abstract available.
Associated factors and effects of comorbid atrial fibrillation in hypertensive patients due to primary aldosteronism.
Sakaguchi S, Okamoto R, Inoue C, Akao M, Kamemura K, Kurihara I, Takeda Y, Ohno Y, Inagaki N, Rakugi H, Katabami T, Tsuiki M, Tanabe A, Tamura K, Fujita S, Yano Y, Dohi K; JRAS investigators; Naruse M. Sakaguchi S, et al. J Hum Hypertens. 2023 Sep;37(9):757-766. doi: 10.1038/s41371-022-00753-2. Epub 2022 Sep 24. J Hum Hypertens. 2023. PMID: 36153382
Potential Identification of Type 2 Diabetes with Elevated Insulin Clearance.
Sugiyama S, Jinnouchi H, Hieshima K, Kurinami N, Jinnouchi K, Yoshida A, Suzuki T, Kajiwara K, Miyamoto F, Jinnouchi T. Sugiyama S, et al. Among authors: suzuki t. NEJM Evid. 2022 Apr;1(4):EVIDoa2100052. doi: 10.1056/EVIDoa2100052. Epub 2022 Mar 15. NEJM Evid. 2022. PMID: 38319210
234 results